Diflomotecan

Diflomotecan Uses, Dosage, Side Effects, Food Interaction and all others data.

Diflomotecan is under investigation in clinical trial NCT00080015 (Diflomotecan (BN80915) Administered Once Every 3 Weeks in Treating Patients With Sensitive Small Cell Lung Cancer (SCLC)).

Trade Name Diflomotecan
Generic Diflomotecan
Diflomotecan Other Names Diflomotecan
Type
Formula C21H16F2N2O4
Weight Average: 398.366
Monoisotopic: 398.107813329
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Diflomotecan
Diflomotecan

Innovators Monograph

You find simplified version here Diflomotecan

*** Taking medicines without doctor's advice can cause long-term problems.
Share